Sistemic Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Sistemic General Information
Description
Developer of microRNA analysis technology intended to offer products for the bioprocessing, cell therapy and drug discovery and development markets. The company focuses on the analysis of the information content of microRNA and other non-coding RNAs for applications in the development of cell therapies and drug repositioning, enabling healthcare professionals to easily develop cell therapies and drug repositioning without any hassle.
Contact Information
Website
www.sistemic.co.ukCorporate Office
- Campbell House, Central Business Park
- Greenside Road
- Glasgow ML1 5FL
- Scotland, United Kingdom
Corporate Office
- Campbell House, Central Business Park
- Greenside Road
- Glasgow ML1 5FL
- Scotland, United Kingdom
Sistemic Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | 01-Dec-2025 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 10-Apr-2020 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 11-Jan-2018 | Completed | Generating Revenue | |||
| 5. Grant | 22-Jun-2017 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 26-Dec-2015 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 22-Oct-2014 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 18-Nov-2013 | $327K | $1.32M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 17-Mar-2010 | $990K | $990K | Completed | Generating Revenue |
Sistemic Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 362,242 | $0.000122 | $0.91 | $0.91 | 1x | $0.91 | 20.45% | |
| Ordinary | 106,600 | $0.000122 | $0.36 | $0.36 | 1x | $0.36 | 6.02% |
Sistemic Patents
Sistemic Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260275416-A1 | Cell contamination assay | Pending | 20-Jul-2020 | ||
| GB-201809336-D0 | Cell contamination assay | Inactive | 06-Jun-2018 | ||
| GB-201809337-D0 | Cell contamination assay | Inactive | 06-Jun-2018 | ||
| GB-201809338-D0 | Cell contamination assay | Inactive | 06-Jun-2018 | ||
| GB-201809238-D0 | Call contamination assay | Inactive | 05-Jun-2018 |
Sistemic Signals
Sistemic Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ChimaeraBio | Corporation | Minority |
Sistemic FAQs
-
When was Sistemic founded?
Sistemic was founded in 2007.
-
Where is Sistemic headquartered?
Sistemic is headquartered in Glasgow, United Kingdom.
-
What is the size of Sistemic?
Sistemic has 8 total employees.
-
What industry is Sistemic in?
Sistemic’s primary industry is Drug Discovery.
-
Is Sistemic a private or public company?
Sistemic is a Private company.
-
What is Sistemic’s current revenue?
The current revenue for Sistemic is .
-
How much funding has Sistemic raised over time?
Sistemic has raised $3.93M.
-
Who are Sistemic’s investors?
ChimaeraBio has invested in Sistemic.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process